Abstract
Background Predominantly attributed to metabolic disruptions, individuals with diabetes are more prone to kidney stones than the general population. The Body Rounds Index (BRI), a new measure of obesity and health risks, has been shown to have a positive correlation with the risk of developing kidney stones. Our study sets out to explore the correlation between BRI and kidney stones specifically within the diabetic population.
Methods Leveraging data from the National Health and Nutrition Examination Survey (NHANES) spanning 2011 to 2018, this cross-sectional study probed the link between BRI and kidney stones among diabetic individuals. We conducted a logistic regression analysis to investigate the relationship between BRI and kidney stones, with adjustments for various covariates. To further explore the association trends between different BRI levels and the incidence of kidney stones, we categorized BRI into four levels, thereby enhancing the robustness of our results. Additionally, subgroup and sensitivity analyses were performed to ensure the reliability and consistency of our findings.
Results A total of 3,558 diabetic patients were included in this study, of whom 546 (15.3%) had kidney stones. After adjusting for some and all confounders, we observed that the prevalence of kidney stones in diabetic patients increased by 7% and 5% for each unit increase in BRI in Models 2 and 3, respectively (Model 2: OR=1.07, 95% CI: 1.03-1.11; Model 3: OR=1.05, 95% CI: 1.00-1.09).This association remained statistically significant when the BRI was divided into quartiles, the prevalence of kidney stones in the highest quartile of BRI (Q4) was 50% greater than in the lowest quartile (Q1) (OR=1.50, 95% CI: 1.14-1.98; P<0.05).
Conclusions Our research indicates a positive correlation between BRI and the incidence of kidney stones among diabetics. We believe that BRI may be an effective indicator for assessing the risk of kidney stones in diabetic patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The survey protocol for the NHANES was approved by CDC's National Center for Health Statistics Institutional Research Ethics Review Board. All participants provided written informed consent, and the study was approved by the NCHS Research Ethics Review Board(https://wwwn.cdc.gov/nchs/nhanes/default.aspx).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
